ToSyMa study results phase 1: +48% detection rate for invasive breast tumors

More

SOMATEX at Master of Disaster in Essen, Germany

More

SOMATEX at the Senology Congress 2022

More

Celebrating 30 years of innovation at SOMATEX

More

Patients benefit from partnership between SOMATEX and HOLOGIC

More

SOMATEX at Master of Disaster 2021 ON-SITE and ONLINE

More

SOMATEX online at the Senology Congress 2021

More

SOMATEX participates in NCoBC the 2021

More

Tumark Vision: Highest detection rate in SenTa-Study

More